Sarah K. Moore, PhD, LCSW
Senior Research Scientist, Center for Technology and Behavioral Health
Sarah K. Moore, PhD, MSW is a behavioral researcher specializing in mixed methods research. Her primary research interests focus on opioid use among adolescents and young adults, pain, and optimizing evidence-based prevention of, and treatment approaches for opioid use disorder. Dr. Moore received a MA in Religious Studies from the University of Chicago, a MSW from Columbia University, and a PhD in Social Work from the University of Illinois at Chicago. Her dissertation research involved the design and implementation of an intervention to facilitate social work students’ consideration of the consequences of taking a harm reduction approach to their work with clients who use substances. Dr. Moore completed a post-doctoral training program at NDRI, Inc. where she was fortunate to work with Dr. Lisa Marsch on several projects related to her primary research interests. Dr. Moore is leading a large scoping review of peer reviewed literature (2000-2021) that includes people who identify as African American/Black, Hispanic/Latinx, and American Indian/Alaskan Native in substance use treatment using technology-based interventions; she is currently serving as a Co-Investigator/Qualitative Methods lead on NIDA CTN-0116 – Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder. Additionally, she is supporting analyses on Dr. Milan Satcher’s qualitative sub-study as part of the larger JCOIN study with Corrections and community partners in NH. Finally, she has collaborated with Dr. Zev Schuman-Olivier on several of his mindfulness-focused studies to support the recovery of people with opioid use disorder and is particularly interested in self-compassion as a key mechanism to aid recovery.
Selected Publications
- Marsch LA, Moore SK, Borodovsky JT, Solhkhah R, Badger GJ, Semino S, Jarrett K, Condon KD, Rossettie K, Vincent P, Hajizadeh N, Ducat E. A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults. Addiction. 2016 Aug;111(8):1406-15. doi: 10.1111/add.13363. PMID: 26918564; PMCID: PMC4940230.
- Lord SE, Moore SK, Ramsey A, Dinauer S, Johnson K. Implementation of a substance use recovery support mobile application in community settings: Qualitative study of clinician and staff perspectives of facilitators and barriers. JMIR Mental Health. 2016;3(2):e24. PMCID: PMC4942682.
- Moore SK, Mattaini MA. US social work students’ attitudes shift favorably towards a harm reduction approach to AOD practice: The effectiveness of consequence analysis. Social Work Education: The International Journal. 2014;33(6): p.788-804.
- Moore SK, Guarino H, Marsch LA. "This is not who I want to be:" experiences of opioid-dependent youth before, and during, combined buprenorphine and behavioral treatment. Subst Use Misuse. 2014 Feb;49(3):303-14. doi: 10.3109/10826084.2013.832328. PMID: 24041131; PMCID: PMC5839470.
- Moore SK, Guarino H, Acosta MC, Aronson ID, Marsch LA, Rosenblum A, Grabinski MJ, Turk DC. Patients as collaborators: Using focus groups and feedback sessions to develop an interactive, web-based self-management intervention for chronic pain Pain Medicine. 2013;14(11):1730-40. PMID: 23859438. PMCID: PMC3834126.
- Moore SK, Marsch LA, Badger GJ, Solhkhah R, Hofstein Y. Improvement in psychopathology among opioid-dependent adolescents during behavioral-pharmacological treatment. J Addict Med. 2011 Dec;5(4):264-71. doi: 10.1097/ADM.0b013e3182191099. PMID: 22107875; PMCID: PMC3223378.